227 related articles for article (PubMed ID: 19334049)
1. Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms.
Iacobini C; Menini S; Ricci C; Scipioni A; Sansoni V; Mazzitelli G; Cordone S; Pesce C; Pugliese F; Pricci F; Pugliese G
J Pathol; 2009 Jul; 218(3):360-9. PubMed ID: 19334049
[TBL] [Abstract][Full Text] [Related]
2. Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms.
Iacobini C; Menini S; Ricci C; Scipioni A; Sansoni V; Cordone S; Taurino M; Serino M; Marano G; Federici M; Pricci F; Pugliese G
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):831-6. PubMed ID: 19359660
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.
Iacobini C; Menini S; Ricci C; Blasetti Fantauzzi C; Scipioni A; Salvi L; Cordone S; Delucchi F; Serino M; Federici M; Pricci F; Pugliese G
J Hepatol; 2011 May; 54(5):975-83. PubMed ID: 21145823
[TBL] [Abstract][Full Text] [Related]
4. Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice.
Iacobini C; Oddi G; Menini S; Amadio L; Ricci C; Di Pippo C; Sorcini M; Pricci F; Pugliese F; Pugliese G
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F611-21. PubMed ID: 15870382
[TBL] [Abstract][Full Text] [Related]
5. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.
Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Salvi L; Pesce CM; Relucenti M; Familiari G; Taurino M; Pugliese G
Cardiovasc Res; 2013 Dec; 100(3):472-80. PubMed ID: 23975852
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor.
Iacobini C; Menini S; Oddi G; Ricci C; Amadio L; Pricci F; Olivieri A; Sorcini M; Di Mario U; Pesce C; Pugliese G
FASEB J; 2004 Nov; 18(14):1773-5. PubMed ID: 15361471
[TBL] [Abstract][Full Text] [Related]
7. Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).
Baba SP; Hellmann J; Srivastava S; Bhatnagar A
Chem Biol Interact; 2011 May; 191(1-3):357-63. PubMed ID: 21276777
[TBL] [Abstract][Full Text] [Related]
8. Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation.
Menini S; Iacobini C; Ricci C; Oddi G; Pesce C; Pugliese F; Block K; Abboud HE; Giorgio M; Migliaccio E; Pelicci PG; Pugliese G
Diabetologia; 2007 Sep; 50(9):1997-2007. PubMed ID: 17611735
[TBL] [Abstract][Full Text] [Related]
9. Novel inhibitors of glycation and AGE formation.
Rahbar S
Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884
[TBL] [Abstract][Full Text] [Related]
10. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.
Al-Hussaini H; Kilarkaje N
Toxicol Appl Pharmacol; 2018 Jan; 339():97-109. PubMed ID: 29229234
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
12. Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why.
Mol M; Degani G; Coppa C; Baron G; Popolo L; Carini M; Aldini G; Vistoli G; Altomare A
Redox Biol; 2019 May; 23():101083. PubMed ID: 30598328
[TBL] [Abstract][Full Text] [Related]
13. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
[TBL] [Abstract][Full Text] [Related]
14. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs.
Tikellis C; Thomas MC; Harcourt BE; Coughlan MT; Pete J; Bialkowski K; Tan A; Bierhaus A; Cooper ME; Forbes JM
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E323-30. PubMed ID: 18477705
[TBL] [Abstract][Full Text] [Related]
15. Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions.
Teissier T; Quersin V; Gnemmi V; Daroux M; Howsam M; Delguste F; Lemoine C; Fradin C; Schmidt AM; Cauffiez C; Brousseau T; Glowacki F; Tessier FJ; Boulanger E; Frimat M
Aging Cell; 2019 Apr; 18(2):e12850. PubMed ID: 30794349
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products modulates oxidative stress and mitochondrial function in the soleus muscle of mice fed a high-fat diet.
Velayoudom-Cephise FL; Cano-Sanchez M; Bercion S; Tessier F; Yu Y; Boulanger E; Neviere R
Appl Physiol Nutr Metab; 2020 Oct; 45(10):1107-1117. PubMed ID: 32289236
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms of lipid injury in the glomerulus.
Schlondorff D
Am J Kidney Dis; 1993 Jul; 22(1):72-82. PubMed ID: 8322798
[TBL] [Abstract][Full Text] [Related]
18. Role of advanced glycation end products in cellular signaling.
Ott C; Jacobs K; Haucke E; Navarrete Santos A; Grune T; Simm A
Redox Biol; 2014; 2():411-29. PubMed ID: 24624331
[TBL] [Abstract][Full Text] [Related]
19. Lipoxidation in cardiovascular diseases.
Gianazza E; Brioschi M; Fernandez AM; Banfi C
Redox Biol; 2019 May; 23():101119. PubMed ID: 30833142
[TBL] [Abstract][Full Text] [Related]
20. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.
Miyata T; Sugiyama S; Suzuki D; Inagi R; Kurokawa K
Kidney Int Suppl; 1999 Jul; 71():S54-6. PubMed ID: 10412738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
